Clinical Reviews
Authors:
Ruiz López Da, Arana Argüelles-Cañedo Cb, Sánchez Salvador Jc, Fernández Martina Cd, Serrano Pereza Je, Gallardo Alonso Ff
bPediatra. CS Los Pedroches. Leganés, Madrid. España.
Reference of this article.:
Ruiz López D, Arana Argüelles-Cañedo C, Sánchez Salvador J, Fernández Martina C, Serrano Pereza J, Gallardo Alonso F. Uso de inhibidores de la bomba de protones en la infancia y adolescencia. Rev Pediatr Aten Primaria. 2004;6:579-582..
Published in Internet: 31/12/2004
Abstract:
The Proton Pump Inhibitors (PPI) are a therapeutical group very frequently used in adults. However the inherent characteristics of children and adolescents limit the absorption, metabolization and distribution of these drugs. PPI have been used in the treatment of Gastroesophageal Reflux Disease (GERD) and related esophageal diseases, peptic ulcer and H. pylori therapy. There are not clinical trials with every PPI, Omeprazole and Lansoprazole are the best known. It should be adjusted the dosage range for these ages, sometimes higher than adults. There are second generation PPI drugs that should be studied in childhood. Its use is limited by difficult posology and administration in these patients.Keywords: Child. Gastroesophageal reflux disease. Drug therapy.
El contenido íntegro del artículo estará disponible en formato web próximamente. Mientras tanto puede descargarlo en formato Acrobat Reader (PDF).
Comments
This article has no comments yet.